The medical technology company Invent Medic has resolved on a directed cash issue of approximately SEK 2.3 million at a price of SEK 0.28 per share, corresponding to a discount of approximately 15 percent, according to a press release. The issue is directed to existing shareholders and external investors and is intended to strengthen the company's capital structure as well as finance continued growth and commercialization. The new share issue comprises up to 8.3 million new shares and entails dilution of approximately 7 percent.